On November 23, 2022, a Class II recall was initiated for Desmopressin Acetate Tablets 0.2mg. The recall, identified as D-0072-2023, was classified by the FDA as Class II.
The stated reason for the recall was subpotent drug. The affected product was Desmopressin Acetate Tablets 0.2mg, packaged in 100-count bottles, Rx Only, with NDC 23155-490-01. The product was distributed by Avet Pharmaceuticals Inc. of East Brunswick, NJ.
The recall was carried out by Heritage Pharmaceuticals Inc. As of the latest update, the recall status is listed as terminated.
This recall reflects a specific finding tied to the affected lots described in the FDA record. It does not indicate that desmopressin as a compound is unsafe. The classification and reason are reported here as stated in the recall record, without additional interpretation.
Readers seeking general information about desmopressin, including its approved uses and regulatory status, can consult the compound overview for further context.